Skip to content
HowShorted

Fulgent Genetics, Inc. short interest in 2020

In 2020, Fulgent Genetics, Inc.'s disclosed short interest ran from 1.55% of shares outstanding on 15 Jan 2020 to 16.13% on 31 Dec 2020, a change of +14.58 percentage points. The year's high was 16.13% on 31 Dec 2020 and its low 1.33% on 31 Jan 2020, averaging 5.90% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.38 days on 30 Oct 2020. Full history: Fulgent Genetics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Fulgent Genetics, Inc. in 2020

2020 in figures

Start of year
1.55% (15 Jan 2020)
End of year
16.13% (31 Dec 2020)
Change
+14.58 pp
High
16.13% (31 Dec 2020)
Low
1.33% (31 Jan 2020)
Average
5.90%
Highest days to cover
4.38 (30 Oct 2020)
SEC filings marked
8

Every report in 2020

Fulgent Genetics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20201.55%1.14
31 Jan 20201.33%1.31
14 Feb 20201.95%1.50
28 Feb 20201.96%1.16
13 Mar 20202.08%1.20results (8-K), 10-K filed
31 Mar 20202.43%1.25
15 Apr 20202.74%2.08
30 Apr 20203.57%2.01
15 May 20203.53%1.48results (8-K), 10-Q filed
29 May 20203.54%2.00
15 Jun 20203.20%2.51
30 Jun 20204.32%1.53
15 Jul 20204.70%2.09
31 Jul 20204.38%2.16
14 Aug 20204.24%1.23results (8-K), 10-Q filed
31 Aug 20205.41%1.06
15 Sep 20207.09%1.43
30 Sep 20208.80%1.53
15 Oct 20208.18%2.56
30 Oct 20209.59%4.38
13 Nov 202012.47%2.7610-Q filed, results (8-K)
30 Nov 202015.09%2.04
15 Dec 202013.21%1.82
31 Dec 202016.13%2.50

See also: Fulgent Genetics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.